JNJ - JOHNSON & JOHNSON

246.75
-1.810   -0.734%

Share volume: 5,752,328
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%
$248.56
-1.81
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
61%
Profitability 53%
Dept financing 39%
Liquidity 75%
Performance 71%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.68%
1 Month
5.24%
3 Months
21.86%
6 Months
38.03%
1 Year
49.17%
2 Year
54.37%
Key data
Stock price
$246.75
P/E Ratio 
18.66
DAY RANGE
$244.36 - $247.88
EPS 
$11.13
52 WEEK RANGE
$141.50 - $251.71
52 WEEK CHANGE
$49.44
MARKET CAP 
500.242 B
YIELD 
2.48%
SHARES OUTSTANDING 
2.410 B
DIVIDEND
$1.30
EX-DIVIDEND DATE
02-24-2026
NEXT EARNINGS DATE
07-16-2025
BETA 
0.05
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,994,723
AVERAGE 30 VOLUME 
$9,336,243
Company detail
CEO: Joaquin Duato
Region: US
Website: jnj.com
Employees: 152,700
IPO year: 1970
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands. Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. MedTech segment provides electrophysiology products to treat cardiovascular diseases.

Recent news